Search

Integra LifeSciences Holdings Corp

Cerrado

SectorSanidad

17.05 -3.51

Resumen

Variación precio

24h

Actual

Mínimo

16.98

Máximo

17.6

Métricas clave

By Trading Economics

Ingresos

9.2M

4.6M

Ventas

27M

419M

BPA

0.56

Margen de beneficios

1.103

Empleados

4,427

EBITDA

-35M

28M

Recomendaciones

By TipRanks

Recomendaciones

Neutral

Estimación a 12 Meses

+9.11% upside

Dividendos

By Acuity

Próximas Ganancias

29 oct 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-129M

1.4B

Apertura anterior

20.56

Cierre anterior

17.05

Noticias sobre sentimiento de mercado

By Acuity

25%

75%

72 / 340 Clasificación en Healthcare

Integra LifeSciences Holdings Corp Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

6 ago 2026, 19:36 UTC

Integra Lifesciences Holdings Corp shares are lower today, continuing a decline since Wednesday's close. The stock remains below its 20-day moving average.

5 ago 2026, 19:36 UTC

Integra Lifesciences Holdings Corp shares are lower today, continuing a decline since Tuesday's close. The stock remains significantly below its 20-day moving average.

4 ago 2026, 19:46 UTC

Integra Lifesciences Holdings Corp shares are lower during Tuesday's session, approximately 3.60% below the 20-day moving average, with no specific news identified.

3 ago 2026, 20:51 UTC

Integra Lifesciences Holdings Corp gains in after-market hours, reflecting broader market optimism despite no specific company news. Major indices also show significant increases.

31 jul 2026, 19:46 UTC

Integra Lifesciences Holdings Corp shares are lower during Friday's session, trading near the lower end of their one-month range with no specific news identified.

30 jul 2026, 17:41 UTC

Integra Lifesciences Holdings Corp shares are higher today, despite earlier session pullbacks. No specific news was identified to explain the movement.

29 jul 2026, 21:01 UTC

Integra Lifesciences shares are lower in after-market hours, reflecting a broader decline in U.S. equities amid rising oil prices and geopolitical tensions.

28 jul 2026, 20:03 UTC

News

Shares of Integra Lifesciences Holdings are higher, supported by UBS's Neutral rating and price target of $19 amid broader Health Care Equipment gains.

27 jul 2026, 19:51 UTC

Integra Lifesciences Holdings Corp shares are lower today amid notable volatility, despite remaining near the upper end of their one-month trading range.

24 jul 2026, 19:02 UTC

News

Integra Lifesciences shares are higher today, following a downgrade from Wall Street Zen and a price target increase from Truist Financial to $19.00.

21 jul 2026, 18:46 UTC

Integra Lifesciences Holdings shares are higher amid broader market recovery, despite a slight pullback from earlier gains. The stock remains above its 20-day moving average.

20 jul 2026, 19:26 UTC

News

Integra Lifesciences Holdings is lower amid broader market pressure from rising Treasury yields. Investors await upcoming quarterly results after exceeding earnings expectations.

Comparación entre iguales

Cambio de precio

Integra LifeSciences Holdings Corp previsión

Precio Objetivo

By TipRanks

9.11% repunte

Estimación a 12 Meses

Media 19.29 USD  9.11%

Máximo 25 USD

Mínimo 17 USD

De acuerdo con 9 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Integra LifeSciences Holdings Corp Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

9 ratings

1

Comprar

6

Mantener

2

Vender

Sentimiento

By Acuity

72 / 340 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura alcista notoria

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Integra LifeSciences Holdings Corp

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
help-icon Live chat